nu skin enterprises inc - a
(NUS:New York)

Executive Profile*

Background*

Dr. Joseph Y. Chang, Joe, PhD has been the Chief Scientific Officer and Executive Vice President of Product Development at Nu Skin Enterprises Inc. since February 2006. Dr. Chang serves as Chief Scientific Officer and President of Pharmanex LLC. He serves as the Chief Scientific Officer and Executive Vice President of Product Development at Nu Skin International Inc. Dr. Chang served as the President of Pharmanex division, a natural healthcare division at Nu Skin Enterprises ... from April 2000 to February 2006. He served as a Senior Pharmaceutical Executive at two major pharmaceutical companies, Wyeth-Ayerst Research and Rhone Poulenc Rorer, where he was involved in researching natural products for arthritis and cancer treatment. Dr. Chang served as Vice President for Clinical affairs and Pharmacology of Pharmanex from 1997 to April 2000. He served as the President and Chief Scientific Officer of Binary Therapeutics Inc. from 1994 to 1997 and at OAS from 1991 to 1994. Dr. Chang has been a Director of Optimer Pharmaceuticals, Inc. since November 1998. He served as Lead Independent Director of Optimer Pharmaceuticals, Inc. from May 2010 to February 2013. Early in his professional career, he was The Arthritis Foundation fellow at The Johns Hopkins University School of Public. He is a member of New York Academy of Sciences, and American Society of Pharmacology and Experimental Therapeutics. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research during his 20 years in the healthcare industry. He serves on the Board of Directors of a major trade association (CHPA) related to consumer health products in U.S. He had co-edited a textbook on inflammation and developed a series of monographs on botanical products as a source of information for consumers and health professionals. He also holds several patents on new drugs. Dr. Chang received a B.S. degree from Portsmouth University and obtained his Ph.D. in pharmacology from the University of London and conducted post-doctoral research at The Johns Hopkins University School of Public Health and Hygiene.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
NUS:US	$61.63 USD	-0.80

COMPETITOR COMPENSATION